Skip to main content
. 2014 Oct 8;307(12):F1355–F1362. doi: 10.1152/ajprenal.00407.2014

Fig. 2.

Fig. 2.

Relaxin treatment does not affect renal cortex abundance of NO synthase (NOS) 1 (A and B) or NOS3 (C). Western blot analysis of expression of NOS isoforms in the kidney cortex from control (CON), relaxin-treated (RLX), ANG II hypertensive (ANG), and ANG II hypertensive with relaxin treatment (ANG+RLX) rats; n = 6–9. *P < 0.05 vs. control. D: representative Western blots for the expression of NOS1 and NOS3. MW, molecular weight marker; +, positive control; C, control; R, relaxin-treated; A, ANG II hypertensive; AR, ANG II hypertensive with relaxin treatment.